Search Results - Ross, Leorah H.

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Encore - a Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy: 24-Month Results

    Encore - a Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients Stabilized on Enzyme Replacement Therapy... by Rosenbloom, Barry E., Cox, Timothy M., Drelichman, Guillermo I., Cravo, Renata, Balwani, Manisha, Burrow, Thomas Andrew, Martins, Ana Maria, Lukina, Elena, Ross, Leorah H., Angell, Jennifer, Peterschmitt, Judith

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Structure and Expression of Novel Spliced Leader RNA Genes in Caenorhabditis elegans(∗)

    Structure and Expression of Novel Spliced Leader RNA Genes in Caenorhabditis elegans(∗) by Ross, Leorah H., Freedman, Jonathan H., Rubin, Charles S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Engage - a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Eliglustat in Adults with Gaucher Disease Type 1: Results after 18 Months

    Engage - a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Eliglustat in Adults with Gaucher Disease Type 1: Res... by Amato, Dominick J, Dasouki, Majed, Packman, Seymour, Pastores, Gregory M., Assouline, Sarit, Balwani, Manisha, Mistry, Pramod, Ortega, Andres, Shankar, Suma, Solano, Maria Helena, Ross, Leorah H., Angell, Jennifer, Peterschmitt, Judith

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Reached Therapeutic Goals

    Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Re... by Andrew Burrow, Thomas, Balwani, Manisha, Cox, Timothy M., Drelichman, Guillermo, Cravo, Renata, Martins, Ana Maria, Lukina, Elena, Rosenbloom, Barry E., Ross, Leorah H., Angell, Jennifer, Puga, Ana Cristina

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Engage: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Study To Investigate The Efficacy and Safety Of Eliglustat In Adults With Gaucher Disease Type 1: 9 Month Results

    Engage: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Study To Investigate The Efficacy and Safety Of Eliglustat In Adults With Gaucher Disease Type 1: 9 Mo... by Shankar, Suma, Lukina, Elena, Amato, Dominick J, Dasouki, Majed, Packman, Seymour, Pastores, Gregory M, Assouline, Sarit, Balwani, Manisha, Mistry, Pramod K, Ross, Leorah H, Marulkar, Sachin, Peterschmitt, M. Judith

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months

    ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Res... by Mistry, Pramod, Amato, Dominick J., Dasouki, Majed, Packman, Seymour, Pastores, Gregory M., Assouline, Sarit, Balwani, Manisha, Ortega, Andres, Shankar, Suma, Solano, Maria Helena, Ross, Leorah H., Angell, Jennifer, Peterschmitt, M. Judith

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18 months

    ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Res... by Mistry, Pramod, Amato, Dominick J., Dasouki, Majed, Packman, Seymour, Pastores, Gregory M., Assouline, Sarit, Balwani, Manisha, Ortega, Andres, Shankar, Suma, Solano, Maria Helena, Ross, Leorah H., Angell, Jennifer, Peterschmitt, M. Judith

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results

    ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy:... by Cox, Timothy M., Drelichman, Guillermo I., Cravo, Renata, Balwani, Manisha, Burrow, Thomas Andrew, Martins, Ana Maria, Lukina, Elena, Rosenbloom, Barry E., Ross, Leorah H., Angell, Jennifer, Peterschmitt, M. Judith

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 4 Years of Treatment

    Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 4 Years of Treatment by Peterschmitt, M. Judith, Lukina, Elena, Watman, Nora, Dragosky, Marta, Pastores, Gregory M, Arreguin, Elsa Avila, Rosenbaum, Hanna, Zimran, Ari, Sysoeva, Elena, Aguzzi, Rasha, Ross, Leorah H, Puga, Ana Cristina

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years

    Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years by Peterschmitt, M. Judith, Lukina, Elena, Watman, Nora, Dragosky, Marta, Iastrebner, Marcelo, Pastores, Gregory, Arreguin, Elsa Avila, Phillips, Mici, Rosenbaum, Hanna, Sysoeva, Elena, Aguzzi, Rasha, Ross, Leorah H, Puga, Ana Cristina

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial

    Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial by Peterschmitt, M. Judith, Kamath, Ravi S, Lukina, Elena, Watman, Nora, Dragosky, Marta, Iastrebner, Marcelo, Pastores, Gregory M, Arreguin, Elsa Avila, Phillips, Mici, Rosenbaum, Hanna, Sysoeva, Elena, Aguzzi, Rasha, Ross, Leorah H, Puga, Ana Cristina, Rosenthal, Daniel I

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: